Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia

Clinical trial NCT00611247 · COMPLETED

Trial details

NCT number: NCT00611247
Sponsor: Bruno C. Medeiros
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid

Start date: 2007-12-01
Primary completion: 2009-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.